LONDON, Jan. 3, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 120 companies including many key and niche players such as -
Advanced Dermatology Corporation
Anacor Pharmaceuticals, Inc.
Baxter Laboratories Pty. Ltd.
Bayer AG
Beiersdorf AG
Download the full report: https://www.reportbuyer.com/product/4484195/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Medicated Skin Care Products: Medical Solutions for Skin Health Needs.............. II-1 Convergence of Beauty and Healthcare II-2 Growth Drivers in a Nutshell..............II-3 Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver II-4 Major Skin Diseases: Few Fast Facts II-4 Global Market Outlook..............II-5 Developed Markets: Traditional Revenue Contributors II-5 Developing Countries Continue to Offer Significant Growth Opportunities.............. II-6 Table 1: Global Medicated Skin Care Products Market - Geographic Regions Ranked by CAGR (Value Sales) for 2015-2022: Asia-Pacific, Rest of World, Latin America, USA, Canada, Europe, and Japan (includes corresponding Graph/Chart).............. II-7
2. MARKET TRENDS, ISSUES & DRIVERS II-8 Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth II-8 Health & Wellness Boosts Demand for Dermocosmetics II-8 Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver II-8 Major Anti-Aging Ingredients of Cosmeceuticals II-10 Popular Cosmeceutical Contents..............II-10 Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential II-11 Table 2: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart) II-11
Table 3: Global Population by Age-Group: Percentage Change Over the Period 2010-2050 (includes corresponding Graph/Chart).............. II-11
Table 4: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)..............II-12 Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market.............. II-13 Common Skin Care Cosmeceuticals II-14 Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration..............II-15 Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions II-16 Medicated Skin Care Innovations: Spearheading Growth II-17 Innovations for Acne..............II-17 Innovations for Actinic Keratosis II-18 Innovations for Tuberous Sclerosis Complex and Angiofibromas II-18 Melasma Treatment Innovations II-18 Onychomycosis Treatment Innovations II-18 Innovations for Alopecia/Hair Loss II-19 Stem Cell Technology: The New Frontier? II-19 Intelligent Scanning for Identifying Beneficial Ingredients II-20 Innovations in Anti-Aging Skin Care II-20 Other Noteworthy Medicated Skin Care Innovations II-24 Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products..............II-24 What's Next in Ingredients?..............II-24 Innovative Ingredients Gain Focus II-25 Aesthetic Dermatology to Witness Sustained Growth II-25 Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market..............II-26 Surging Popularity of Multi-Functional Products Promote Market Expansion.............. II-27 Sales of Hydroquinone-free Products Gain Momentum II-27 Facial Wipes Offers Huge Untapped Growth Potential II-28 Women: The Dominant Consumer Cluster for Medicated Skin Care Products.............. II-28 Physiological Differences Entail Need for Male Specific Products II-28 Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand..............II-30 Increasing Environmental Pollution Drive Demand for Anti- Pollution Skin Care Products..............II-30 Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care..............II-31 Table 5: World Urban Population in Thousands: 1950-2050P ( includes corresponding Graph/Chart) II-32 Table 6: Degree of Urbanization Worldwide: Urban Population as a Percentage of Total Population by Geographic Region for the Years 1990, 2014 & 2050 (includes corresponding Graph/Chart).............. II-33
3. REGULATORY FRAMEWORK.............. II-34 The Food, Drug, and Cosmetic Act (FD&C Act) II-34 The Concept of "Intended Use"..............II-34 Skin Care Products Continue to Dodge Stringent US FDA Regulations II-35 Regulatory Differences for Skin Care Products and Drugs II-35 FDA getting into the Act..............II-35 National Advertising Division Concentrates on Big Three II-36
4. PRODUCT OVERVIEW.............. II-37 Introduction.............. II-37 Basic Structure of Skin..............II-37 Types of Skin.............. II-37 Skin Diseases and their Treatment II-38 Acne.............. II-38 Treatment Options.............. II-38 Causative Factors.............. II-38 Acne Rosacea.............. II-39 Dry Skin.............. II-39 Fungal Infections..............II-39 Actinic Keratosis..............II-39 Eczema/Atopic Dermatitis..............II-39 Psoriasis.............. II-40 Calluses.............. II-40 Friction Blisters..............II-40 Black Heel and Palm..............II-40 Tennis Toe.............. II-40 Acne Mechanica.............. II-41 The Crucial Role of Nutrition..............II-41 Deficiencies and Select Skin Disorders II-41 Dermatitis.............. II-41 Treatment.............. II-41 B Vitamins.............. II-41 Vitamin A.............. II-42 Vitamin C.............. II-42 Eczema.............. II-42 Treatment.............. II-42 Antioxidants.............. II-42 Selenium.............. II-42 Essential Fatty Acids..............II-42 Psoriasis.............. II-42 Treatment.............. II-43 Vitamin D Analogs..............II-43 Vitamin A Derivatives..............II-43 Zinc.............. II-43 Selenium.............. II-43 Essential Fatty Acids..............II-43
5. PRODUCT LAUNCHES/APPROVALS..............II-44 NeoStrata Launches ProSystem Retinol Peel II-44 SkinFix Launches ExtraStrength Adult Skincare Product & Eczema Treatment for Kids.............. II-44 Skinbetter Science Introduces Clinical Skin Care Line II-44 Galderma Receives Positive Opinion from EU Regulatory Agencies for EPIDUO.............. II-44 Adigica Health Launches BioClarity™ Acne Treatment II-44 FDA Approves Differin Gel 0.1% for OTC Acne Treatment II-44 Medimetriks Submits NDA for Impetigo Treatment Cream II-44 Ceramax Cream by IntraDerm Pharmaceuticals Receives FDA Clearance II-45 FDA Accepts Anacor's NDA for Crisaborole Topical Ointment II-45 Theraderm Launches New Anti-aging Skin Care System II-45 Dapzone Gel by Allergan Receives FDA Approval for Acne Treatment II-45 Galderma's SOOLANTRA® (ivermectin) Cream Approved for Rosacea Patients.............. II-45 Bayer HealthCare Launches Finacea Foam for Rosacea Treatment II-45 Skinvisible Pharmaceuticals Expands Patent Portfolio II-45 Valeant Receives NEA Seal of Approval for CeraVe Baby Products II-45 Galderma Launches Benzac® OTC Acne Solutions II-46 LETI Laboratories' AT4 System Launched in US II-46 Ermis Labs Launches Four New Medicated Skin Care Products II-46
6. RECENT INDUSTRY ACTIVITY..............II-47 Nestlé Skin Health and Pinetree Care Group Collaborate on Skin Care Pilot Study.............. II-47 Cadila Acquires Skincare Brand Melgain from Issar Pharma II-47 Chugai and Galderma Enter into Global License Agreement II-47 Pfizer Acquires Anacor Pharmaceuticals II-47 Nestlé Skin Health Enters into Agreement with Guthy-Renker LLC II-47 Galderma Enters into Alliance with Maruho of Japan II-47 Otsuka and Medimetriks Enter Into Licensing Agreement II-47 Unilever to Acquire Clinical Skincare Brand Murad II-48 Ermis Labs Enters into Licensing Agreement with ICTV for its CoralActives Brand.............. II-48
7. FOCUS ON SELECT GLOBAL PLAYERS..............II-49 Advanced Dermatology Corporation (USA) II-49 Anacor Pharmaceuticals, Inc. (USA) II-49 Baxter Laboratories Pty. Ltd. (Australia) II-49 Bayer AG (Germany)..............II-50 Beiersdorf AG (Germany)..............II-50 Chattem, Inc. (USA).............. II-51 Curatio Healthcare India Pvt. Ltd. (India) II-51 Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany) II-51 EltaMD, Inc. (USA)..............II-51 Episciences, Inc. (USA)..............II-52 Galderma S.A. (Switzerland)..............II-52 IntraDerm™ Pharmaceuticals (USA) II-52 Johnson & Johnson (USA)..............II-53 Kao Corporation (Japan)..............II-53 La Prairie Group AG (Switzerland) II-54 Laboratorios Leti SL. (Spain)..............II-54 L'Oréal S.A. (France)..............II-54 Medimetriks Pharmaceuticals, Inc. (USA) II-55 Merz North America (USA)..............II-55 NEOCUTIS (USA).............. II-55 Otsuka Pharmaceutical Co., Ltd. (Japan) II-56 PCA Skin (USA).............. II-56 Pfizer Consumer Healthcare Limited (USA) II-56 Prestige Brands (USA)..............II-56 RéVive Skincare (USA)..............II-57 Shiseido Co., Ltd. (Japan)..............II-57 SkinCeuticals (USA).............. II-57 SkinMedica, Inc. (USA)..............II-57 Skinvisible Pharmaceuticals, Inc. (USA) II-58 Taisho Pharmaceuticals Co., Ltd. (Japan) II-58 The Himalaya Drug Company (India) II-58 Unilever NV (Netherlands)..............II-59 Valeant Pharmaceuticals International, Inc. (Canada) II-59 Obagi Medical Products, Inc. (USA) II-59 Vivier Pharma (Canada)..............II-60 ZO® Skin Health Inc. (USA)..............II-60
8. GLOBAL MARKET PERSPECTIVE..............II-61 Table 7: World Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-61
Table 8: World Historic Review for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-62
Table 9: World 14-Year Perspective for Medicated Skin Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-63
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Aging Population: A Significant Demand Booster for the Medicated Skin Care Market..............III-1 Table 10: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart) III-1
Table 11: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart) III-2 Baby-Boomers and Working Females Propel Demand for Medicated Skin Care Products..............III-2 Natural Formulations Revive Growth in the Sluggish Skin Care Market.............. III-3 FDA Proposes Ban on Hydroquinone in Skin Care Products III-3 Busy Lifestyles Spur Demand for Products with Anti-Stress Claims.............. III-4 Blemish Balms Attracts Attention III-4 Competitive Landscape..............III-4 Table 12: Leading Players in the US Dermatologicals Market (2016): Percentage Market Share Breakdown for Johnson & Johnson, Bayer, Sanofi, GSK, Pfizer, Prestige Brands and Others (includes corresponding Graph/Chart) III-5 Product Launches..............III-5 Strategic Corporate Developments III-7 Select Key Players..............III-8 B.Market Analytics..............III-14 Table 13: US Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-14
Table 14: US Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-15
2. CANADA.............. III-16 A.Market Analysis.............. III-16 Anti-Aging Cosmeceuticals: A High Growth Segment III-16 Table 15: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart) III-16 Competitive Landscape..............III-17 Table 16: Leading Players in the Canadian Dermatologicals Market (2016): Percentage Market Share Breakdown for McNeil Consumer, Bayer, Prestige Brands, and Others (includes corresponding Graph/Chart)..............III-17 Product Launch.............. III-17 Select Key Players..............III-18 B.Market Analytics..............III-19 Table 17: Canadian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-19
Table 18: Canadian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-20
3. JAPAN.............. III-21 A.Market Analysis.............. III-21 Aging Population, Growing Awareness and Rising Women Workforce Drives Market Demand III-21 Table 19: Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart) III-21 Regulatory Overview..............III-22 Competitive Landscape..............III-22 Select Key Players..............III-22 B.Market Analytics..............III-24 Table 20: Japanese Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-24
Table 21: Japanese Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-25
4. EUROPE.............. III-26 A.Market Analysis.............. III-26 European Skin Care Market: A Macro Perspective III-26 Despite Economic Woes, Anti-Aging Skin Care Market Continue to Witness Healthy Growth..............III-26 Table 22: Aging Population in Europe by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).............. III-27 B.Market Analytics..............III-28 Table 23: European Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-28
Table 24: European Historic Review for Medicated Skin Care Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-29
Table 25: European 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of European Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-30
4a. FRANCE.............. III-31 A.Market Analysis.............. III-31 Competitive Landscape..............III-31 Table 26: Leading Players in the French Dermatologicals Market (2016): Percentage Market Share Breakdown for Johnson & Johnson Santé Beauté, Laboratoires Pierre Fabre, Cooperation Pharmaceutique Francaise / Cooper and Others (includes corresponding Graph/Chart) III-31 L'Oréal S.A.: A Major France-Based Company III-31 B.Market Analytics..............III-32 Table 27: French Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-32
Table 28: French Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-33
4b. GERMANY.............. III-34 A.Market Analysis.............. III-34 Competitive Landscape..............III-34 Table 29: Leading Players in the German Dermatologicals Market (2016): Percentage Market Share Breakdown for GSK, Bayer, and Others (includes corresponding Graph/Chart) III-34 Product Launch.............. III-34 Select Key Players..............III-34 B.Market Analytics..............III-36 Table 30: German Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-36
Table 31: German Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-37
4c. ITALY.............. III-38 Market Analysis.............. III-38 Table 32: Italian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-38
Table 33: Italian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-39
4d. THE UNITED KINGDOM..............III-40 A.Market Analysis.............. III-40 Rising Demand for OTC Medicines Drive Market Growth III-40 Table 34: OTC Drug Market in UK by Category (2015): Percentage Share Breakdown of Analgesics, Cough and Cold Preparations, Medicated Skin Care Products, and Others (includes corresponding Graph/Chart) III-40
Table 35: Leading Categories in OTC Skin Care Sales in the UK (2015): Percentage Share Value Breakdown for Antifungals, Antiseptic Products, Cold Sore Treatments, Cystitis Treatments, Deworming Treatments, Dry Skin Treatments, Feminine Lubricants, Hemorrhoid Treatments, Insect Bite Treatments, Medicated Skincare Treatment, Scalp Treatments, and Wart Treatments (includes corresponding Graph/Chart).............. III-41 Competitive Landscape..............III-42 Table 36: Leading Players in the UK Dermatologicals Market (2016): Percentage Market Share Breakdown for Bayer, GlaxoSmithKline, and Others (includes corresponding Graph/Chart).............. III-42 Strategic Corporate Development III-42 GlaxoSmithKline Plc: A Major UK-Based Company III-42 B.Market Analytics..............III-43 Table 37: UK Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-43
Table 38: UK Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-44
4e. SPAIN.............. III-45 A.Market Analysis.............. III-45 Laboratorios Leti SL: A Major Spain-Based Company III-45 B.Market Analytics..............III-46 Table 39: Spanish Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-46
Table 40: Spanish Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-47
4f. RUSSIA.............. III-48 Market Analysis.............. III-48 Table 41: Russian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-48
Table 42: Russian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-49
4g. REST OF EUROPE.............. III-50 A.Market Analysis.............. III-50 Product Approval..............III-50 Strategic Corporate Developments III-50 Select Key Players..............III-51 B.Market Analytics..............III-53 Table 43: Rest of European Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-53
Table 44: Rest of European Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-54
5. ASIA-PACIFIC.............. III-55 A.Market Analysis.............. III-55 Medicated Skin Brightening and Lightening Products: A High Growth Market.............. III-55 Asian Aesthetics Market..............III-55 B.Market Analytics..............III-56 Table 45: Asia-Pacific Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-56
Table 46: Asia-Pacific Historic Review for Medicated Skin Care Products by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-57
Table 47: Asia-Pacific 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-58
5a. CHINA.............. III-59 A.Market Analysis.............. III-59 Table 48: OTC Drug Market in China by Category (2015): Percentage Share Breakdown of Analgesics, GI Drugs, Medicated Skincare Products, Traditional Medicines, and Others (includes corresponding Graph/Chart) III-59 Strategic Corporate Development III-60 B.Market Analytics..............III-60 Table 49: Chinese Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-60
Table 50: Chinese Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-61
5b. INDIA.............. III-62 A.Market Analysis.............. III-62 Strategic Corporate Development III-62 Select Key Players..............III-62 B.Market Analytics..............III-63 Table 51: Indian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-63
Table 52: Indian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-64
5c. REST OF ASIA PACIFIC..............III-65 A.Market Analysis.............. III-65 Select Regional Markets..............III-65 Australia: Aging Population Drives the Dermatologicals Market III-65 Table 53: Aging Population in Australia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart) III-65 Baxter Laboratories Pty. Ltd.: A Major Australia- Based Company.............. III-66 South Korea.............. III-66 Taiwan: Skin Problems of Modern Consumers Spurs Market Demand III-66 Thailand: Thai Beauty Ingredients Gain Popularity in the West III-66 Increasing Pollution Levels Drive Sales of Skin Care Products III-67 Table 54: Leading Dermatologicals Players in Thailand (2016): Percentage Market Share Breakdown for GSK, Sanofi, and Others (includes corresponding Graph/Chart) III-67 B.Market Analytics..............III-68 Table 55: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-68
Table 56: Rest of Asia-Pacific Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-69
6. LATIN AMERICA.............. III-70 Market Analysis.............. III-70 Table 57: Latin American Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-70
Table 58: Latin American Historic Review for Medicated Skin Care Products by Geographic Region/Country - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-71
Table 59: Latin American 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-72
6a. BRAZIL.............. III-73 A.Market Analysis.............. III-73 Relatively Lesser Share of Medicated Skin Care in OTC Sales Spell Opportunities..............III-73 Table 60: OTC Drug Market in Brazil by Category (2015): Percentage Share Breakdown of Analgesics, Cough and Cold Preparations, Medicated Skincare Products, Vitamins & Minerals, and Others (includes corresponding Graph/Chart) III-73 B.Market Analytics..............III-74 Table 61: Brazilian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-74
Table 62: Brazilian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-75
6b. REST OF LATIN AMERICA..............III-76 A.Market Analysis.............. III-76 Mexico: Competitive Landscape..............III-76 Table 63: Leading Dermatologicals Players in Mexico (2016): Percentage Share Breakdown for Genomma Lab, Bayer de México, and Others (includes corresponding Graph/Chart) III-76 B.Market Analytics..............III-77 Table 64: Rest of Latin American Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-77
Table 65: Rest of Latin American Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-78
7. REST OF WORLD.............. III-79 A.Market Analysis.............. III-79 United Arab Emirates: Increasing Consumer Willingness Drive Sales.............. III-79 Competitive Landscape..............III-79 Table 66: Leading Dermatologicals Players in the UAE (2016): Percentage Share Breakdown for Bayer, J&J, GSK, and Others (includes corresponding Graph/Chart) III-79 B.Market Analytics..............III-80 Table 67: Rest of World Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-80
Table 68: Rest of World Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-81
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 120 (including Divisions/Subsidiaries - 127)
The United States (58) Canada (3) Japan (11) Europe (45) - France (7) - Germany (8) - The United Kingdom (8) - Spain (1) - Rest of Europe (21) Asia-Pacific (Excluding Japan) (9) Middle-East (1)
Download the full report: https://www.reportbuyer.com/product/4484195/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article